242(top 1%)
papers
5.0K(top 1%)
citations
36(top 1%)
h-index
62(top 1%)
g-index
407
all documents
5.6K
doc citations
1.5K
citing journals

Top Articles

#TitleJournalYearCitations
1Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphomaNature Genetics2015315
2Exploratory trial of a biepitopic CAR T-targeting B cell maturation antigen in relapsed/refractory multiple myelomaProceedings of the National Academy of Sciences of the United States of America2019266
3Transfection of chimeric anti‐CD138 gene enhances natural killer cell activation and killing of multiple myeloma cellsMolecular Oncology2014215
4Identification of functional cooperative mutations of SETD2 in human acute leukemiaNature Genetics2014213
5Posttraumatic stress symptoms of health care workers during the corona virus disease 2019Clinical Psychology and Psychotherapy2020161
6Critical regulation of miR-200/ZEB2 pathway in Oct4/Sox2-induced mesenchymal-to-epithelial transition and induced pluripotent stem cell generationProceedings of the National Academy of Sciences of the United States of America2013158
7Ubiquitylation of p62/sequestosome1 activates its autophagy receptor function and controls selective autophagy upon ubiquitin stressCell Research2017143
8Thymic Damage, Impaired Negative Selection, and Development of Chronic Graft-versus-Host Disease Caused by Donor CD4+ and CD8+ T CellsJournal of Immunology2013142
9Homoharringtonine and omacetaxine for myeloid hematological malignanciesJournal of Hematology and Oncology2014118
10The resistance mechanisms of proteasome inhibitor bortezomibBiomarker Research2013117
11Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchinaBlood2015102
12Point Mutation of the Proteasome β5 Subunit Gene Is an Important Mechanism of Bortezomib Resistance in Bortezomib-Selected Variants of Jurkat T Cell Lymphoblastic Lymphoma/Leukemia LineJournal of Pharmacology and Experimental Therapeutics200899
13MicroRNA-451 regulates stemness of side population cells via PI3K/Akt/mTOR signaling pathway in multiple myelomaOncotarget201584
14Overexpression of the PSMB5 gene contributes to bortezomib resistance in T-lymphoblastic lymphoma/leukemia cells derived from Jurkat lineExperimental Hematology200880
15Clinical and biological characteristics of adult biphenotypic acute leukemia in comparison with that of acute myeloid leukemia and acute lymphoblastic leukemia: a case series of a Chinese populationHaematologica200977
16Different mutants of PSMB5 confer varying bortezomib resistance in T lymphoblastic lymphoma/leukemia cells derived from the Jurkat cell lineExperimental Hematology200970
17Prognostic role of serum total cholesterol and high-density lipoprotein cholesterol in cancer survivors: A systematic review and meta-analysisClinica Chimica Acta201870
18Adjuvant therapy in the treatment of gallbladder cancer: a meta-analysisBMC Cancer201560
19Single Nucleotide Polymorphisms of Toll-Like Receptor 4 Decrease the Risk of Development of Hepatocellular CarcinomaPLoS ONE201159
20Kinetics of normal hematopoietic stem and progenitor cells in a Notch1-induced leukemia modelBlood200958
21Increased IL-23 and IL-17 expression by peripheral blood cells of patients with primary biliary cirrhosisCytokine201358
22Therapeutic effects of CSF1R-blocking antibodies in multiple myelomaLeukemia201857
23Multicenter phase ii study of a combination of cyclosporine a, methotrexate and mycophenolate mofetil for GVHD prophylaxis: results of the Chinese Bone Marrow Transplant Cooperative Group (CBMTCG)Journal of Hematology and Oncology201456
24Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma: China Continuation studyJournal of Hematology and Oncology201756
25Bortezomib inhibits maturation and function of osteoclasts from PBMCs of patients with multiple myeloma by downregulating TRAF6Leukemia Research200955
26Thymidine phosphorylase exerts complex effects on bone resorption and formation in myelomaScience Translational Medicine201653
27HDAC1 and Klf4 interplay critically regulates human myeloid leukemia cell proliferationCell Death and Disease201452
28The ubiquitin ligase HERC4 mediates c-Maf ubiquitination and delays the growth of multiple myeloma xenografts in nude miceBlood201649
29Characteristics of acute myeloid leukemia with myelodysplasia‐related changes: A retrospective analysis in a cohort of Chinese patientsAmerican Journal of Hematology201448
30Small-molecule inhibitors targeting INK4 protein p18INK4C enhance ex vivo expansion of haematopoietic stem cellsNature Communications201547
31Diagnostic accuracy of cytokeratin-19 fragment (CYFRA 21–1) for bladder cancer: a systematic review and meta-analysisTumor Biology201547
32Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)Journal of Hematology and Oncology202247
33Different Normalization Strategies Might Cause Inconsistent Variation in Circulating microRNAs in Patients with Hepatocellular CarcinomaMedical Science Monitor201546
34Prognostic significance of miR-34a and its target proteins of FOXP1, p53, and BCL2 in gastric MALT lymphoma and DLBCLGastric Cancer201445
35Cytokine expression during acute graft-versus-host disease after allogeneic peripheral stem cell transplantationBone Marrow Transplantation200542
36CD133 antibody targeted delivery of gold nanostars loading IR820 and docetaxel for multimodal imaging and near-infrared photodynamic/photothermal/chemotherapy against castration resistant prostate cancerNanomedicine: Nanotechnology, Biology, and Medicine202039
37Allogeneic Peripheral Blood Stem Cell Transplantation is a Promising and Safe Choice for the Treatment of Refractory/Relapsed Acute Myelogenous Leukemia, Even with a Higher Leukemia BurdenBiology of Blood and Marrow Transplantation201338
38Caveolin-1 is a Modulator of Fibroblast Activation and a Potential Biomarker for Gastric CancerInternational Journal of Biological Sciences201537
39A multicenter, open‐label phase II study of recombinant CPT (Circularly Permuted TRAIL) plus thalidomide in patients with relapsed and refractory multiple myelomaAmerican Journal of Hematology201436
40Mouse bone marrow-derived mesenchymal stem cells inhibit leukemia/lymphoma cell proliferation in vitro and in a mouse model of allogeneic bone marrow transplantInternational Journal of Molecular Medicine201535
41A method to establish pure fibroblast and endothelial cell colony cultures from murine bone marrowExperimental Hematology199034
42Chronic nickel‐induced DNA damage and cell death: The protection role of ascorbic acidEnvironmental Toxicology200833
43Cu2+ is required for pyrrolidine dithiocarbamate to inhibit histone acetylation and induce human leukemia cell apoptosisChemico-Biological Interactions200832
444q loss is potentially an important genetic event in MM tumorigenesis: identification of a tumor suppressor gene regulated by promoter methylation at 4q13.3, platelet factor 4Blood200731
45A real-time PCR method for quantifying mixed cashmere and wool based on hair mitochondrial DNATextile Reseach Journal201431
46E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCsJournal of Clinical Investigation201831
47Increased expression of immunosuppressive molecules on intratumoral and circulating regulatory T cells in non-small-cell lung cancer patientsAmerican Journal of Cancer Research201531
48<p>A Novel Liposomal S-Propargyl-Cysteine: A Sustained Release of Hydrogen Sulfide Reducing Myocardial Fibrosis via TGF-β1/Smad Pathway</p>International Journal of Nanomedicine201930
49URI regulates tumorigenicity and chemotherapeutic resistance of multiple myeloma by modulating IL-6 transcriptionCell Death and Disease201428
50C-reactive protein promotes bone destruction in human myeloma through the CD32–p38 MAPK–Twist axisScience Signaling201728